Vantage Point

While industries like retail, hospitality and technology have endeavored to make customer experience a primary driver for innovation, the same cannot be said for most healthcare delivery systems. For decades, patient experience has been shaped by initiatives narrowly aimed at increasing efficiencies, controlling costs and improving outcomes. The Patient Protection and Affordable Care Act, which mandates the creation of accountable care organizations (ACOs), aims to make patient experience and engagement with their health and medical record a primary driver of improved outcomes, efficiency and cost savings.
The goals outlined for ACOs cannot be fully achieved without patient-centered insights and strategies to drive that engagement. To get a true picture of the patient experience, organizations will rely less on traditional silo measurements in favor of more holistic, longitudinal outcomes and experience measurements. While traditional research methods elicit information for many types of mandated objectives, they frequently fall short when a larger, more authentic understanding of the experience with a condition or care team is needed. Instead, researchers can deploy a multi-methods approach including tactics such as: ethnography; guided observations;  in-depth interviews; immediate feedback PDA interviews and daily debriefs; and care team insight workshops.
Patient health-related experiences involve deeply personal decisions, and rich insights are needed to motivate engagement. Regardless of the outcome of the pending health reform, if provider organizations are to achieve the full promise of accountable care, the patient must be in the driver's seat.
Jean Fasching is VP, business development, CMI
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.